Form 4: Foresite Labs Increases Stake in Alumis Inc. with Recent Stock Purchases

Foresite Labs, a significant shareholder in Alumis Inc. (ALMS), has increased its indirect holdings through recent common stock purchases.

Summary

• Foresite Labs, LLC, along with related entities, filed a Form 4 detailing changes in beneficial ownership of Alumis Inc. (ALMS) common stock.
• On May 2, 2025, Foresite Labs acquired 25,000 shares at $4.62 per share.
• On May 6, 2025, Foresite Labs acquired 20,000 shares at $4.34 per share.
• These transactions increased Foresite Labs' indirect holdings to 4,227,670 and then 4,247,670 shares respectively through Foresite Capital Fund VI, L.P.
• Additional indirect holdings are attributed to Foresite Capital Fund V, L.P. (5,584,889 shares), Labs Co-Invest V, LLC (194,459 shares), Foresite Capital Opportunity Fund V, L.P. (2,034,129 shares), Foresite Labs Fund I, L.P. (1,960,337 shares), and Foresite Labs Affiliates 2021, LLC (1,176,470 shares).
• Foresite Labs and related entities disclaim beneficial ownership of the shares held by the various funds and LLCs, except to the extent of their pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock purchases, indicating continued investment but without explicit positive or negative commentary.

Positives

• Increased investment by Foresite Labs could signal confidence in Alumis Inc.'s future prospects.

Risks

• The document indicates indirect ownership and disclaimers of beneficial ownership, which could complicate the understanding of Foresite Labs' actual control and influence over Alumis Inc.

Industry Context

Form 4 filings are standard disclosures for significant shareholders, providing transparency into their trading activities. This filing indicates continued investment by a major shareholder in a publicly traded company.

Stakeholder Impact

• The increased stake by Foresite Labs could be viewed positively by shareholders, potentially increasing investor confidence.

Key Dates

Keywords

Alumis Inc., Foresite Labs, beneficial ownership, Form 4, stock purchase, investment